ombitasvir
Showing 101 - 110 of 110
DAA-based Therapy in HCV/HIV-Coinfected Patients
Unknown status
- Hepatitis C, Chronic
- Human Immunodeficiency Virus
- DAA against HCV
-
Seville, SpainValme University Hospital
Oct 14, 2016
Hepatitis C Trial (12 weeks without Ribavirin, 12 weeks with Ribavirin, 24 weeks with Ribavirin)
Unknown status
- Hepatitis C
- 12 weeks without Ribavirin
- +2 more
- (no location specified)
Jan 4, 2016
Liver Transplantation Trial (treatment of HCV with oral direct acting antiviral therapy)
Completed
- Liver Transplantation
- treatment of HCV with oral direct acting antiviral therapy
- (no location specified)
Apr 25, 2017
Hepatitis C Virus Infection in Patients With Hemoglobinopathies
Completed
- Hepatitis C, Chronic
- Hemoglobinopathies
- Antiviral drugs
- (no location specified)
May 9, 2017
Chronic Hepatitis C Virus Infection Trial in Puerto Rico, United States (ABT-333, Placebo for ABT-333, Pegylated interferon)
Completed
- Chronic Hepatitis C Virus Infection
- ABT-333
- +3 more
-
Anaheim, California
- +7 more
Jun 1, 2018
Healthy Volunteer Trial in Shanghai (ABT-450/r/ABT-267, ABT-333)
Completed
- Healthy Volunteer
-
Shanghai, ChinaSite Reference ID/Investigator# 137655
Oct 15, 2015
Direct Antiviral Agents on Hepatitis C Virus Arthropathy
Unknown status
- Hepatitis C
- Antiviral agents
-
Assiut, Egyptyasmin AbdElazim Mohamed Turkey
Jul 19, 2017
Hepatitis C, Chronic Trial in Busan, Yangsan (Daclinza and Sunvepra)
Unknown status
- Hepatitis C, Chronic
- Daclinza and Sunvepra
-
Busan, Korea, Republic of
- +1 more
Dec 24, 2015